We have dozens of randomized clinical trials that concluded there aren’t tangible prognostic benefits from coronary revascularization in some patients with single or multi-vessel coronary artery disease who are suffering from cardiomyopathy. Such lack of benefit may be explained by non-explored presence of co-incidental non-ischemic cardiomyopathy. Thus, the same patient may have both ischaemic and […]

There is no denying that the main target during PCI are significant proximal lesions in the three main coronary vessels (LAD, RCA and LCX), but sometimes we are faced with ostial significant lesions in sizable side branches that shouldn’t be overlooked (especially, OM and diagonals). We are focusing here on MEDINA 0,0,1 ostial bifurcational affection […]